Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY)

RICFY Revenue

Recordati Industria Chimica e Farmaceutica had revenue of 632.32M EUR in the quarter ending September 30, 2025, with 13.44% growth. This brings the company's revenue in the last twelve months to 2.55B, up 12.58% year-over-year. In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B with 12.45% growth.

• Revenue (ttm): 2.55B EUR
• Revenue Growth: +12.58%
• P/S Ratio: 3.84
• Revenue / Employee: 557.42K EUR
• Employees: 4,583
• Market Cap: 11.52B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.34B	259.23M	12.45%
Dec 31, 2023	2.08B	229.02M	12.36%
Dec 31, 2022	1.85B	273.23M	17.29%
Dec 31, 2021	1.58B	131.21M	9.06%
Dec 31, 2020	1.45B	-32.98M	-2.23%